What question did this study set out to answer?

To evaluate recent evidence characterizing lysine pyruvylation as an epigenetic and metabolic regulator, while defining the validation steps required for translational applications.

September 17, 2026EMBO Molecular MedicineOpen Access

Lysine pyruvylation: decoding the molecular language of pyruvate signaling

View Full Paper

Ask AI

Bookmark

Authors

JZJun Zhang

Discussion

Member takes

Overview

Scientific commentary reviews lysine pyruvylation across immune and chromatin pathways, highlighting evidence gaps needed before clinical or biomarker translation.

Key Points

To evaluate recent evidence characterizing lysine pyruvylation as an epigenetic and metabolic regulator, while defining the validation steps required for translational applications.
Synthesized molecular findings from initial mechanistic studies identifying lysine pyruvylation (Kpy) substrates and enzymatic writers and erasers.
Assessed functional impacts on STAT1 signaling and histone-mediated transcriptional activation linked to glycolytic flux.
Outlined empirical criteria necessary to demonstrate human disease relevance, including tissue abundance and target occupancy metrics.
STAT1 K201 pyruvylation suppresses type I interferon signaling by disrupting STAT1–STAT2 complex assembly.
HAT1 and p300 act as enzymatic writers while SIRT3 functions as an eraser of histone Kpy, coupling glycolytic flux to active chromatin states.
Causal links to human pathology remain unestablished due to a lack of quantitative tissue occupancy measurements and clinical correlation data.

Cite This Study

Jun Zhang (2026) studied this question.

synapsesocial.com/papers/6aabb6e95f706d05830e5a80 https://doi.org/10.1038/s44321-026-00522-5

View Full Paper

Ask AI

Bookmark

September 17, 2026EMBO Molecular MedicineOpen Access

Lysine pyruvylation: decoding the molecular language of pyruvate signaling

View Full Paper

Ask AI

Bookmark

Authors

JZJun Zhang

Discussion

Member takes

Overview

Scientific commentary reviews lysine pyruvylation across immune and chromatin pathways, highlighting evidence gaps needed before clinical or biomarker translation.

Key Points

To evaluate recent evidence characterizing lysine pyruvylation as an epigenetic and metabolic regulator, while defining the validation steps required for translational applications.
Synthesized molecular findings from initial mechanistic studies identifying lysine pyruvylation (Kpy) substrates and enzymatic writers and erasers.
Assessed functional impacts on STAT1 signaling and histone-mediated transcriptional activation linked to glycolytic flux.
Outlined empirical criteria necessary to demonstrate human disease relevance, including tissue abundance and target occupancy metrics.
STAT1 K201 pyruvylation suppresses type I interferon signaling by disrupting STAT1–STAT2 complex assembly.
HAT1 and p300 act as enzymatic writers while SIRT3 functions as an eraser of histone Kpy, coupling glycolytic flux to active chromatin states.
Causal links to human pathology remain unestablished due to a lack of quantitative tissue occupancy measurements and clinical correlation data.

Cite This Study

Jun Zhang (2026) studied this question.

synapsesocial.com/papers/6aabb6e95f706d05830e5a80 https://doi.org/10.1038/s44321-026-00522-5

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark